It is interesting that CTCL-enriched DCs showed higher expression of Galectin LGALS9 and the gene encoding the tumor necrosis factor (TNF) ligand TNFSF12, molecules known to negatively regulate TH1 cell immunity47 and mediate tumor immune responses48 (Fig. 6c). This evidence concerns the gene LGALS9 and neoplasm.